Transcriptomic and molecular evidence for baclofen-associated modulation of inhibitory synaptic and neuroinflammatory pathways in diabetic neuropathic pain.

Ye K, Wang Q, Chen H, Xie S, Ye K

Open source

DOI
10.3389/fphar.2026.1917799
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1917799,
  title = {Transcriptomic and molecular evidence for baclofen-associated modulation of inhibitory synaptic and neuroinflammatory pathways in diabetic neuropathic pain.},
  author = {Ye K and Wang Q and Chen H and Xie S and Ye K},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1917799},
  url = {https://doi.org/10.3389/fphar.2026.1917799}
}

RIS

TY  - JOUR
TI  - Transcriptomic and molecular evidence for baclofen-associated modulation of inhibitory synaptic and neuroinflammatory pathways in diabetic neuropathic pain.
AU  - Ye K
AU  - Wang Q
AU  - Chen H
AU  - Xie S
AU  - Ye K
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1917799
UR  - https://doi.org/10.3389/fphar.2026.1917799
ER  - 

APA

K, Y., Q, W., H, C., S, X., & K, Y. (2026). Transcriptomic and molecular evidence for baclofen-associated modulation of inhibitory synaptic and neuroinflammatory pathways in diabetic neuropathic pain.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1917799

Source records